Focusing on ground-breaking medicines to address chronic progressive
diseases, including rheumatology and dermatology.
Investing in new pathways, technologies and approaches to tackle the
most widespread and debilitating cancers.
Discovering compounds that have the potential to treat chronic
disabling neurological conditions and impairments, including MS,
Parkinson’s Disease and Alzheimer's.
Partnering with patient advocates and leading stakeholders to help
address unmet needs across the world for people living with AIDS and
Seeking solutions for a range of diseases that currently have few or
no treatments, including cystic fibrosis, endometriosis, uterine
fibroids and diabetic nephropathy.